Evidence for reversal of multidrug resistance by quinine in LR73 cells without alteration of nuclear pirarubicin uptake and down-regulation of mdr1 gene expression

International Journal of Cancer

Volumn 73, Issue 4, 1997, Pages 600-606

  Belhoussine, Rajae ^a   Morjani, Hamid ^a   Lahlil, Rachid ^a   Manfait, Michel ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 BIS(ALLYLAMINO) 6 [4 [[2,2 BIS(4 FLUOROPHENYL)ETHYL]AMINO]PIPERIDINO] 1,3,5 TRIAZINE; PIRARUBICIN; QUININE; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; DOWN REGULATION; DRUG UPTAKE; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; MICROFLUOROMETRY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL NUCLEUS; CHO CELLS; CRICETINAE; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION; GENES, MDR; P-GLYCOPROTEIN; PIPERIDINES; QUININE; TRIAZINES; VERAPAMIL;

EID: 0031468429     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971114)73:4<600::AID-IJC23>3.0.CO;2-B     Document Type: Article

References (24)

1. BENNIS, S., ICHAS, F. and ROBERT, J., Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line. Int. J. Cancer, 62, 283-290 (1995).
2. CHEVILLARD, S., POUILLART, P., BELDJORD, C., ASSELAIN, B., BEUZEBOC, P., MAGDELÉNAT, H. and VIELH, P., Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. Cancer, 77, 292-300 (1996).
3. CHOMCZYNSKI, P. and SACCHI, N., Single-step-method of RNA isolation by acid suanidiniumthiocyanatephenolchloroform extraction. Anal. Biochem., 162, 156-159 (1987).
4. ESCRIBA, P.V., FERRER-MONTIEL, A.V., FERRAGUT, J.A. and GONZALEZ-ROS, J.M., Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug resistance phenomena. Biochemistry, 29, 7275-7282 (1990).
5. ESCRIBA, P.V., SASTRE, M. and GARCIA-SEVILLA, J.A., Disruption of cellular signaling pathways by daunomycin through destabilization of nonlamellar membrane structures. Proc. nat. Acad. Sci. (Wash.), 92, 7595-7599 (1995).
6. GIGLI, M., DOGLIA, S., MILLOT, J.M., VALENTINI, L. and MANFAIT, M. Quantitative study of doxorubicin in living cell nuclei by microspectrofluorometry. Biochem. Biophys. Acta., 950, 13-20 (1988).
7. GOTTESMAN, M.M. and PASTAN, I., Biochemistry of multidrug-resistance mediated by the multidrug transporter. Ann. Rev. Biochem., 62, 385-427 (1993).
8. GROS, P., BEN NERIAH, Y., GROOP, J. and HOUSMAN, D.E., Isolation and expression of a complementary DNA that confers multidrug resistance. Nature (Lond.)., 323, 728-731 (1986).
9. HERZOG, C.E., TSOKOS, M., BATES, S.E. and FOJO, A.T., Increased MDR/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J. biol. Chem., 268, 2964-2952 (1993).
10. HU, Y.P., POURQUIER, P., DOIGNON, F., CROUZET, M. and ROBERT, J., Effects of modulators of multidrug resistance on the expression of the MDR1 gene in human KB cells in culture. Anti-Cancer Drugs, 7, 738-744 (1996).
11. JAFFRÉZOU, J.P., HERBERT, J.M., LEVADE, T., GAU, M.N., CHATLIN, P. and LAURENT, G., Reversal of multidrug resistance by calcium-channel blocker SR 33557 without photo-affinity labeling of P-glycoprotein. J. biol. Chem., 266, 19858-19864 (1991).
12. JAFFRÉZOU, J.P., LEVADE, T., BETTAIEB, A., ANDRIEU, N., BEZOMBES, C., MAESTRE, N., VERMEERSCH, S., ROUSSE, A. and LAURENT, G., Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J., 15, 2417-2424 (1996).
13. LAVIE, Y., CAO, H.T., BURSTEN, S.L., GIULIANO, A.E. and CABOT, M.C., Accumulation of glucosylceramides in multidrug-resistant cancer cells. J. biol. Chem., 271, 19530-19536 (1996).
14. LEHNERT, M., DALTON, W.S., ROE, D., EMERSON, S. and SALMON, S.E., Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in human mycloma cell line model. Blood, 77, 348-354 (1991).
15. LE MOYEC, L., TATOUD, R., DEGEORGES, A., CALABRESSE, C., BAUZA, G., EUGÉNE, M. and CALVO, F., Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line. Cancer Res., 56, 3461-3467 (1996).
16. MILLOT, J.M., JOLY, P., BENOIST, H. and MANFAIT, M., Doxorubicin nuclear distribution necessary to induce erythroid differentiation of K562 cells. J. Cell Pharmacol., 2, 1-8 (1991).
17. MILLOT, J.M., RASOANAIVO, T.W.D., MORJANI, H. and MANFAIT, M., Role of the aclacinomycin A-doxorubicin associated inreversal of doxorubicin resistance in K562 tumour cells. Brit. J. Cancer. 69, 678-684 (1989).
18. MULLER, C., GOUBIN, F., FERRANDIS, E., CORNIL-SCHARWTZ, I., BAILLY, J.D., BORDIER, C., BÉNARD, J., SIKIC, I. and LAURENT, G., Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells. Mol. Pharmacol., 47, 51-56 (1995).
19. PLOSKER, G.L. and FAULDS, D., Epirubicin: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in cancer chemotherapy. Drugs, 45, 788-856 (1993).
20. SEBILLE, S., MORJANI, H., POULLAIN, M. and MANFAIT, M. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry. Anticancer Res., 14, 2389-2393 (1994).
21. SHARONOV, S., CHOURPA, I., VALISA, P., FLEURY, F., FEOFANOV, A. and MANFAIT, M., Confocal spectral imaging analysis. Anal. Chim. Acta, 290, 40-47 (1994).
22. SIMON, S.M. and SCHINDLER, M., Cell biological mechanisms of multidrug resistance in tumors. Proc. nat. Acad. Sci. (Wash.), 91, 3497-3504 (1994).
23. SOGNIER, M.A., ZHANG, Y., EBERLE, R.L., SWEET, K.M., ALTENBERG, G.A. and BELLI, J.A., Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100). Biochem. Pharmacol., 48, 391-401 (1994).
24. ZAMORA, J.M., PEARCE, H.L. and BECK, W.T., Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemia cells. Mol. Pharmacol., 33, 454-462 (1988).